Saudi Arabia-based group's corporate venture capital fund will invest in disruptive technologies and opportunities in the food and retail space.

Equip has raised $17m in total to make eating disorder treatment accessible.

Ensoma has emerged with $70m in series A financing to advance research from Fred Hutchinson and University of Washington.

Takeda Ventures and Alexandria Venture Investments have taken part in a $70m series A round for Ensoma, with Takeda separately signing a strategic collaboration deal.

Dexcel Pharma has co-led a $60m series A round for Immunai, which previously collected $20m in seed financing less than a year ago.

Allianz will receive a minority stake in the financial services technology provider after agreeing to invest $42.2m in funding.

KDDI Open Innovation Fund has thrown its weight behind Swift Navigation, a global positioning technology developer already backed by Qualcomm Ventures.

Eli Lilly has led a series C round for the diabetes treatment developer, which plans to complete preclinical testing of its lead therapy.

Inpex and Nanto CVC have backed a $14.3m round for the drone services company, which has itself already conducted corporate venturing deals.

Citi and HSBC Ventures contributed to a $19.2m round that will support the data lineage software developer's international growth.